RSV
Cue Health Awarded $28M BARDA Contract to Develop Multiplex Respiratory Test
The molecular test would detect and differentiate among influenza A/B, respiratory syncytial virus, and COVID-19 and deliver results within 25 minutes.
BD Gains FDA Clearance for Combination COVID-19, Flu, RSV Molecular Test
The RT-PCR-based BD Respiratory Viral Panel for BD Max received a CE mark in 2022 and FDA Emergency Use Authorization earlier this year.
Co-Diagnostics Awarded $1.2M From NIH RADx Program for Upper Respiratory Panel
The firm's test for influenza A/B, COVID-19, and respiratory syncytial virus runs on its Co-Dx PCR Home testing platform.
Domus Diagnostics Wins $2.4M NIH RADx Tech Contract
The firm will use the funding to validate a rapid, low-cost, zero-power multiplex assay for COVID-19, flu A and B, and respiratory syncytial virus.
BioMérieux Gets CLIA Waiver for BioFire SpotFire Respiratory Panel Mini
The CLIA waiver now allows the SpotFire system and two existing panels to be used by non-lab professionals at the point of care, the firm said.